Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide DNA Oligonucleotide Synthesis market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 4.8% during the forecast period.
This report presents the market size and development trends by detailing the DNA Oligonucleotide Synthesis market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the DNA Oligonucleotide Synthesis market will be shown in this report. In short, this report will comprehensively reveal the characteristics of DNA Oligonucleotide Synthesis industry and will help you to build a panoramic view of the industrial development.
DNA Oligonucleotide Synthesis Market, By Type:
Primers
Probes
Intermediate-scale Synthesis Oligos
Large-scale Synthesis Oligos
Linkers and Adaptors
DNA Oligonucleotide Synthesis Market, By Application:
Commercial
Academic Research
Some of the leading players are as follows:
Eurofins Genomics
Genewiz
BBI
DNA 20 (ATUM)
Bio Basic
SBS Genetech
Genescript
DNA 2.0 (ATUM)
IDT
Gene Oracle
OriGene
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 DNA Oligonucleotide Synthesis Market: Technology Type Analysis
-
4.1 DNA Oligonucleotide Synthesis Technology Type Market Share Analysis, 2018 & 2026
-
4.2 DNA Oligonucleotide Synthesis Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Primers
4.3.2 Probes
4.3.3 Intermediate-scale Synthesis Oligos
4.3.4 Large-scale Synthesis Oligos
4.3.5 Linkers and Adaptors
5 DNA Oligonucleotide Synthesis Market: Product Analysis
-
5.1 DNA Oligonucleotide Synthesis Product Market Share Analysis, 2018 & 2026
-
5.2 DNA Oligonucleotide Synthesis Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 DNA Oligonucleotide Synthesis Market: Application Analysis
-
6.1 DNA Oligonucleotide Synthesis Application Market Share Analysis, 2018 & 2026
-
6.2 DNA Oligonucleotide Synthesis Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Commercial
6.3.2 Academic Research
7 DNA Oligonucleotide Synthesis Market: Regional Analysis
-
7.1 DNA Oligonucleotide Synthesis Regional Market Share Analysis, 2018 & 2026
-
7.2 DNA Oligonucleotide Synthesis Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 Eurofins Genomics
9.1.1 Eurofins Genomics Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 Genewiz
9.2.1 Genewiz Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 BBI
9.3.1 BBI Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 DNA 20 (ATUM)
9.4.1 DNA 20 (ATUM) Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 Bio Basic
9.5.1 Bio Basic Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 SBS Genetech
9.6.1 SBS Genetech Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Genescript
9.7.1 Genescript Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 DNA 2.0 (ATUM)
9.8.1 DNA 2.0 (ATUM) Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 IDT
9.9.1 IDT Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 Gene Oracle
9.10.1 Gene Oracle Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
9.11 OriGene
9.11.1 OriGene Company overview
9.11.2 Financial performance
9.11.3 Product benchmarking
9.11.4 Strategic initiatives
9.11.5 SWOT analysis
The List of Tables and Figures (Totals 100 Figures and 156 Tables)
Figure Primers DNA Oligonucleotide Synthesis market, 2015 - 2026 (USD Million)
Figure Probes DNA Oligonucleotide Synthesis market, 2015 - 2026 (USD Million)
Figure Intermediate-scale Synthesis Oligos DNA Oligonucleotide Synthesis market, 2015 - 2026 (USD Million)
Figure Large-scale Synthesis Oligos DNA Oligonucleotide Synthesis market, 2015 - 2026 (USD Million)
Figure Linkers and Adaptors DNA Oligonucleotide Synthesis market, 2015 - 2026 (USD Million)
Figure Commercial market, 2015 - 2026 (USD Million)
Figure Academic Research market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America DNA Oligonucleotide Synthesis market, by country, 2015 - 2026 (USD Million)
-
Table North America DNA Oligonucleotide Synthesis market, by type, 2015 - 2026 (USD Million)
-
Table North America DNA Oligonucleotide Synthesis market, by product, 2015 - 2026 (USD Million)
-
Table North America DNA Oligonucleotide Synthesis market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. DNA Oligonucleotide Synthesis market, by type, 2015 - 2026 (USD Million)
-
Table U.S. DNA Oligonucleotide Synthesis market, by product, 2015 - 2026 (USD Million)
-
Table U.S. DNA Oligonucleotide Synthesis market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada DNA Oligonucleotide Synthesis market, by type, 2015 - 2026 (USD Million)
-
Table Canada DNA Oligonucleotide Synthesis market, by product, 2015 - 2026 (USD Million)
-
Table Canada DNA Oligonucleotide Synthesis market, by application, 2015 - 2026 (USD Million)
-
Table Europe DNA Oligonucleotide Synthesis market, by country, 2015 - 2026 (USD Million)
-
Table Europe DNA Oligonucleotide Synthesis market, by type, 2015 - 2026 (USD Million)
-
Table Europe DNA Oligonucleotide Synthesis market, by product, 2015 - 2026 (USD Million)
-
Table Europe DNA Oligonucleotide Synthesis market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. DNA Oligonucleotide Synthesis market, by type, 2015 - 2026 (USD Million)
-
Table U.K. DNA Oligonucleotide Synthesis market, by product, 2015 - 2026 (USD Million)
-
Table U.K. DNA Oligonucleotide Synthesis market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany DNA Oligonucleotide Synthesis market, by type, 2015 - 2026 (USD Million)
-
Table Germany DNA Oligonucleotide Synthesis market, by product, 2015 - 2026 (USD Million)
-
Table Germany DNA Oligonucleotide Synthesis market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France DNA Oligonucleotide Synthesis market, by type, 2015 - 2026 (USD Million)
-
Table France DNA Oligonucleotide Synthesis market, by product, 2015 - 2026 (USD Million)
-
Table France DNA Oligonucleotide Synthesis market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy DNA Oligonucleotide Synthesis market, by type, 2015 - 2026 (USD Million)
-
Table Italy DNA Oligonucleotide Synthesis market, by product, 2015 - 2026 (USD Million)
-
Table Italy DNA Oligonucleotide Synthesis market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain DNA Oligonucleotide Synthesis market, by type, 2015 - 2026 (USD Million)
-
Table Spain DNA Oligonucleotide Synthesis market, by product, 2015 - 2026 (USD Million)
-
Table Spain DNA Oligonucleotide Synthesis market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific DNA Oligonucleotide Synthesis market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific DNA Oligonucleotide Synthesis market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific DNA Oligonucleotide Synthesis market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific DNA Oligonucleotide Synthesis market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China DNA Oligonucleotide Synthesis market, by type, 2015 - 2026 (USD Million)
-
Table China DNA Oligonucleotide Synthesis market, by product, 2015 - 2026 (USD Million)
-
Table China DNA Oligonucleotide Synthesis market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan DNA Oligonucleotide Synthesis market, by type, 2015 - 2026 (USD Million)
-
Table Japan DNA Oligonucleotide Synthesis market, by product, 2015 - 2026 (USD Million)
-
Table Japan DNA Oligonucleotide Synthesis market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India DNA Oligonucleotide Synthesis market, by type, 2015 - 2026 (USD Million)
-
Table India DNA Oligonucleotide Synthesis market, by product, 2015 - 2026 (USD Million)
-
Table India DNA Oligonucleotide Synthesis market, by application, 2015 - 2026 (USD Million)
-
Table Latin America DNA Oligonucleotide Synthesis market, by country, 2015 - 2026 (USD Million)
-
Table Latin America DNA Oligonucleotide Synthesis market, by type, 2015 - 2026 (USD Million)
-
Table Latin America DNA Oligonucleotide Synthesis market, by product, 2015 - 2026 (USD Million)
-
Table Latin America DNA Oligonucleotide Synthesis market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil DNA Oligonucleotide Synthesis market, by type, 2015 - 2026 (USD Million)
-
Table Brazil DNA Oligonucleotide Synthesis market, by product, 2015 - 2026 (USD Million)
-
Table Brazil DNA Oligonucleotide Synthesis market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico DNA Oligonucleotide Synthesis market, by type, 2015 - 2026 (USD Million)
-
Table Mexico DNA Oligonucleotide Synthesis market, by product, 2015 - 2026 (USD Million)
-
Table Mexico DNA Oligonucleotide Synthesis market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina DNA Oligonucleotide Synthesis market, by type, 2015 - 2026 (USD Million)
-
Table Argentina DNA Oligonucleotide Synthesis market, by product, 2015 - 2026 (USD Million)
-
Table Argentina DNA Oligonucleotide Synthesis market, by application, 2015 - 2026 (USD Million)
-
Table MEA DNA Oligonucleotide Synthesis market, by country, 2015 - 2026 (USD Million)
-
Table MEA DNA Oligonucleotide Synthesis market, by type, 2015 - 2026 (USD Million)
-
Table MEA DNA Oligonucleotide Synthesis market, by product, 2015 - 2026 (USD Million)
-
Table MEA DNA Oligonucleotide Synthesis market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa DNA Oligonucleotide Synthesis market, by type, 2015 - 2026 (USD Million)
-
Table South Africa DNA Oligonucleotide Synthesis market, by product, 2015 - 2026 (USD Million)
-
Table South Africa DNA Oligonucleotide Synthesis market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria DNA Oligonucleotide Synthesis market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria DNA Oligonucleotide Synthesis market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria DNA Oligonucleotide Synthesis market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table Eurofins Genomics Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Genewiz Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table BBI Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table DNA 20 (ATUM) Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Bio Basic Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table SBS Genetech Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Genescript Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table DNA 2.0 (ATUM) Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table IDT Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Gene Oracle Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table OriGene Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-
